John Q. Adams

Mr. Adams serves as President of J.Q Enterprises, a holding company in real estate and ranching. Mr. Adams had a long career in the pharmaceutical industry and has owned three companies: Baylor Laboratories, sold to Norwich Eaton Pharmaceuticals; his second company, Allerderm, Inc., sold to Virbac Inc. in France; and Adams Laboratories, a private pharmaceutical company focused on respiratory therapy, sold to Medeva Pharmaceuticals, where from 1991 to 1995, Mr. Adams served as President of Medeva Americas. Mr. Adams later repurchased Adams Laboratories from Medeva and served as Chairman and Chief Executive Officer. He currently serves as Chairman of Adams Laboratories. Mr. Adams served as Chairman of Adams Respiratory Therapeutics Inc., until October 14, 2005. He has been Vice Chairman of CereScan, Inc. since June 2009 and its Director since March 2009. Mr. Adams serves as Director of Respirics, Inc. He served as a Director of Adamis Pharmaceuticals Corp. from November 2003 to June 19, 2009. Mr. Adams served as Director of Medeva Americas. He served as a Director of Cellegy Pharmaceuticals Inc., since November 6, 2003. He served as a Director of Adams Respiratory Therapeutics Inc. (Formerly Adams Laboratories, Inc) since 1997. He also retains memberships and board positions in several professional and philanthropic organizations including the American College of Allergy and the Vanderbilt University Voice Center. In July 2007, he was elected to the Board of Trustees for Heidelberg College in Tiffin, OH and in April 2009 was inducted into the Hall of Excellence of the Ohio Foundation of Independent Colleges which each year honors three distinguished graduates from 34 Ohio colleges. He is also an Honorary Fellow of the American Academy of Otolaryncology-Head and Neck Surgery. Mr. Adams holds a Degree in Biology from Heidelberg College.